ANXA1 affects cell proliferation, invasion and epithelial‑mesenchymal transition of oral squamous cell carcinoma

Wan,Ying‑Ming; Tian,Jing; Qi,Ling; Liu,Li‑Mei; Xu,Ning

doi:10.3892/etm.2017.5148

ANXA1 affects cell proliferation, invasion and epithelial‑mesenchymal transition of oral squamous cell carcinoma

Authors:
- Ying‑Ming Wan
- Jing Tian
- Ling Qi
- Li‑Mei Liu
- Ning Xu
View Affiliations

Affiliations: Department of Stomatology, Affiliated Hospital of Jilin Medical University, Jilin 132021, P.R. China, Department of Physiology, Jilin Medical University, Jilin 132013, P.R. China, Department of Pathology, Jilin Medical University, Jilin 132013, P.R. China
Published online on: September 20, 2017 https://doi.org/10.3892/etm.2017.5148
Pages: 5214-5218

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Annexin A1 (ANXA1) acts either as a tumor suppressor or an oncogene in different tumor types. Several clinical studies revealed that the expression of ANXA1 is associated with the pathologic differentiation grade in oral squamous cell carcinoma (OSCC) patients. However, the direct function of ANXA1 in OSCC progression has remained to be fully clarified. The present study was designed to investigate the role of ANXA1 in OSCC cell proliferation and invasion in vitro. Furthermore, whether ANXA1 was involved in transforming growth factor β1 (TGFβ1)/epidermal growth factor (EGF)‑induced epithelial‑mesenchymal transition (EMT) in OSCC was explored. Tca‑8113 and SCC‑9 cells were transfected with ANXA1‑pcDNA3.1 plasmid to overexpress ANXA1. Subsequently, cell proliferation and invasion were examined using MTT and Transwell‑Matrigel invasion assays. TGFβ1 and EGF were used to induce EMT in Tca‑8113 and SCC‑9 cells, and the expression of epithelial (E)‑cadherin, neural (N)‑cadherin and vimentin was determined by western blot analysis. The results demonstrated that ANXA1 overexpression induced a significant decrease of cell growth and invasiveness in Tca‑8113 and SCC‑9 cells. The expression of E‑cadherin was significantly increased, while the expression of vimentin and N‑cadherin was significantly decreased in ANXA1‑overexpressing Tca‑8113 and SCC‑9 cells. ANXA1 expression was significantly decreased in TGFβ1/EGF‑treated cells. Furthermore TGFβ1/EGF‑induced EMT in OSCC cell lines was attenuated by ANXA1 overexpression. In conclusion, to the best of our knowledge, the present study was the first to evidence that ANXA1 inhibits OSCC cell proliferation and invasion in vitro. TGFβ1/EGF‑induced EMT was reversed by ANXA1 in OSCC. ANXA1 was suggested to be a potential marker for OSCC as well as a novel treatment.

View Figures

View References

1	Liu W, Wang YF, Zhou HW, Shi P, Zhou ZT and Tang GY: Malignant transformation of oral leukoplakia: A retrospective cohort study of 218 Chinese patients. BMC Cancer. 10:6852010. View Article : Google Scholar : PubMed/NCBI
2	de Camargo Cancela M, Voti L, Guerra-Yi M, Chapuis F, Mazuir M and Curado MP: Oral cavity cancer in developed and in developing countries: Population-based incidence. Head Neck. 32:357–367. 2010.PubMed/NCBI
3	Hunter KD, Parkinson EK and Harrison PR: Profiling early head and neck cancer. Nat Rev Cancer. 5:127–135. 2005. View Article : Google Scholar : PubMed/NCBI
4	Leemans CR, Braakhuis BJ and Brakenhoff RH: The molecular biology of head and neck cancer. Nat Rev Cancer. 11:9–22. 2011. View Article : Google Scholar : PubMed/NCBI
5	Gobbetti T and Cooray SN: Annexin A1 and resolution of inflammation: Tissue repairing properties and signalling signature. Biol Chem. 397:981–993. 2016. View Article : Google Scholar : PubMed/NCBI
6	Swa HL, Blackstock WP, Lim LH and Gunaratne J: Quantitative proteomics profiling of murine mammary gland cells unravels impact of annexin-1 on DNA damage response, cell adhesion, and migration. Mol Cell Proteomics. 11:381–393. 2012. View Article : Google Scholar : PubMed/NCBI
7	Guzmán-Aránguez A, Olmo N, Turnay J, Lecona E, Pérez-Ramos P, de Silanes López I and Lizarbe MA: Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J Cell Biochem. 94:178–193. 2005. View Article : Google Scholar : PubMed/NCBI
8	Rohwer N, Bindel F, Grimm C, Lin SJ, Wappler J, Klinger B, Blüthgen N, Bois Du I, Schmeck B, Lehrach H, et al: Annexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A. Oncotarget. 7:6693–6710. 2016. View Article : Google Scholar : PubMed/NCBI
9	Fatimathas L and Moss SE: Annexins as disease modifiers. Histol Histopathol. 25:527–532. 2010.PubMed/NCBI
10	Guo C, Liu S and Sun MZ: Potential role of Anxa1 in cancer. Future Oncol. 9:1773–1793. 2013. View Article : Google Scholar : PubMed/NCBI
11	Huang Y, Zhang C, Chen C, Sun S, Zheng H, Wan S, Meng Q, Chen Y and Wei J: Investigation of circulating antibodies to ANXA1 in breast cancer. Tumour Biol. 36:1233–1236. 2015. View Article : Google Scholar : PubMed/NCBI
12	Lin Y, Lin G, Fang W, Zhu H and Chu K: Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype. Med Oncol. 31:3272014. View Article : Google Scholar : PubMed/NCBI
13	Boudhraa Z, Merle C, Mazzocut D, Chezal JM, Chambon C, Miot-Noirault E, Theisen M, Bouchon B and Degoul F: Characterization of pro-invasive mechanisms and N-terminal cleavage of ANXA1 in melanoma. Arch Dermatol Res. 306:903–914. 2014. View Article : Google Scholar : PubMed/NCBI
14	Boudhraa Z, Rondepierre F, Ouchchane L, Kintossou R, Trzeciakiewicz A, Franck F, Kanitakis J, Labeille B, Joubert-Zakeyh J, Bouchon B, et al: Annexin A1 in primary tumors promotes melanoma dissemination. Clin Exp Metastasis. 31:749–760. 2014. View Article : Google Scholar : PubMed/NCBI
15	Gao Y, Chen Y, Xu D, Wang J and Yu G: Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers. BMC Cancer. 14:5202014. View Article : Google Scholar : PubMed/NCBI
16	Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, et al: Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res. 60:6293–6297. 2000.PubMed/NCBI
17	Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL and Ornstein DK: Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res. 8:117–123. 2002.PubMed/NCBI
18	Faria PC, Sena AA, Nascimento R, Carvalho WJ, Loyola AM, Silva SJ, Durighetto AF, Oliveira AD, Oliani SM and Goulart LR: Expression of annexin A1 mRNA in peripheral blood from oral squamous cell carcinoma patients. Oral Oncol. 46:25–30. 2010. View Article : Google Scholar : PubMed/NCBI
19	Nomura H, Uzawa K, Yamano Y, Fushimi K, Nakashima D, Kouzu Y, Kasamatsu A, Ogawara K, Shiiba M, Bukawa H, et al: Down-regulation of plasma membranous Annexin A1 protein expression in premalignant and malignant lesions of the oral cavity: Correlation with epithelial differentiation. J Cancer Res Clin Oncol. 135:943–949. 2009. View Article : Google Scholar : PubMed/NCBI
20	Cheng TY, Wu MS, Lin JT, Lin MT, Shun CT, Huang HY, Hua KT and Kuo ML: Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway. Cancer. 118:5757–5767. 2012. View Article : Google Scholar : PubMed/NCBI
21	Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, Perretti M and Nusrat A: Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem. 281:19588–19599. 2006. View Article : Google Scholar : PubMed/NCBI
22	Fang Y, Guan X, Cai T, Long J, Wang H, Xie X and Zhang Y: Knockdown of ANXA1 suppresses the biological behavior of human NSCLC cells in vitro. Mol Med Rep. 13:3858–3866. 2016. View Article : Google Scholar : PubMed/NCBI
23	Maschler S, Gebeshuber CA, Wiedemann EM, Alacakaptan M, Schreiber M, Custic I and Beug H: Annexin A1 attenuates EMT and metastatic potential in breast cancer. EMBO Mol Med. 2:401–414. 2010. View Article : Google Scholar : PubMed/NCBI
24	Zhu DW, Liu Y, Yang X, Yang CZ, Ma J, Yang X, Qiao JK, Wang LZ, Li J, Zhang CP, et al: Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade. BMC Cancer. 13:3012013. View Article : Google Scholar : PubMed/NCBI
25	Zhu DW, Yang X, Yang CZ, Ma J, Liu Y, Yan M, Wang LZ, Li J, Zhang CP, Zhang ZY and Zhong LP: Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathological differentiation grade. Oral Oncol. 49:542–550. 2013. View Article : Google Scholar : PubMed/NCBI
26	Zhang L, Yang X, Zhong LP, Zhou XJ, Pan HY, Wei KJ, Li J, Chen WT and Zhang ZY: Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma. J Oral Pathol Med. 38:362–370. 2009. View Article : Google Scholar : PubMed/NCBI
27	Przybyla L, Muncie JM and Weaver VM: Mechanical control of Epithelial-to-Mesenchymal transitions in development and cancer. Annu Rev Cell Dev Biol. 32:527–554. 2016. View Article : Google Scholar : PubMed/NCBI
28	Diepenbruck M and Christofori G: Epithelial-mesenchymal transition (EMT) and metastasis: Yes, no, maybe?t. Curr Opin Cell Biol. 43:7–13. 2016. View Article : Google Scholar : PubMed/NCBI
29	Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428. 2009. View Article : Google Scholar : PubMed/NCBI
30	Lin CY, Jeng YM, Chou HY, Hsu HC, Yuan RH, Chiang CP and Kuo MY: Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. J Surg Oncol. 97:544–550. 2008. View Article : Google Scholar : PubMed/NCBI
31	Richter P, Umbreit C, Franz M and Berndt A, Grimm S, Uecker A, Böhmer FD, Kosmehl H and Berndt A: EGF/TGFβ1 co-stimulation of oral squamous cell carcinoma cells causes an epithelial-mesenchymal transition cell phenotype expressing laminin 332. J Oral Pathol Med. 40:46–54. 2011. View Article : Google Scholar : PubMed/NCBI
32	Diamond ME, Sun L, Ottaviano AJ, Joseph MJ and Munshi HG: Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium. J Cell Sci. 121:2197–2207. 2008. View Article : Google Scholar : PubMed/NCBI